The University of Chicago Header Logo

Connection

Walter M. Stadler to Dasatinib

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Dasatinib.
Walter M. Stadler
Connection Strength
0.024
Dasatinib
  1. Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Jun; 30(3):1211-5.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.